Influenza A virus with defective M2 ion channel activity as a live vaccine

Virology

Volumn 299, Issue 2, 2002, Pages 266-270

  Watanabe, Tokiko ^a,b,c,d   Watanabe, Shinji ^a   Kida, Hiroshi ^b   Kawaoka, Yoshihiro ^a,d  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b HOKKAIDO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Influenza A virus; Live attenuated vaccine; M2 ion channel

Indexed keywords

INFLUENZA VACCINE; ION CHANNEL; LIVE VACCINE; PROTEIN M2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; VIRUS IMMUNITY; VIRUS MUTANT;

INFLUENZA A VIRUS; INFLUENZA VIRUS;

EID: 0036434127     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1508     Document Type: Article

References (19)

1. Belshe, R. B., Mendelman, P. M., Treanor, J., King, J., Gruber, W. C., Piedra, P., Bernstein, D. I., Hayden, F. G., Kotloff, K., Zangwill, K., Iacuzio, D., and Wolff, M. (1998). The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N. Engl. J. Med. 338, 1405-1412.
2. Cha, T. A., Kao, K., Zhao, J., Fast, P. E., Mendelman, P. M., and Arvin, A. (2000). Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial. J. Clin. Microbiol. 38, 839-845.
3. Cox, N. J., and Subbarao, K. (1999). Influenza. Lancet 354, 1277-1282.
4. Desselberger, U. (1975). Relation of virus particles counts to the hem-agglutininating activity of influenza virus suspensions measured by the HA pattern test and by use of the photometric HCU method. Arch. Virol. 49, 365-372.
5. Duff, K. C., and Ashley, R. H. (1992). The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers. Virology 190, 485-489.
6. Edwards, K. M., Dupont, W. D., Westrich, M. K., Plummer, W. D., Jr., Palmer, P. S., and Wright, P. F. (1994). A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J. Infect. Dis. 169, 68-76.
7. Fodor, E., Devenish, L., Engelhardt, O. G., Palese, P., Brownlee, G. G., and Garcia-Sastre, A. (1999). Rescue of influenza A virus from recombinant DNA. J. Virol. 73, 704-712.
8. Helenius, A. (1992). Unpacking the incoming influenza virus. Cell 69, 577-578.
9. Herlocher, M. L., Maassab, H. F., and Webster, R. G. (1993). Molecular and biological changes in the cold-adapted "master strain" A/AA/6/60 (H2N2) influenza virus. Proc. Natl. Acad. Sci. USA 90, 6032-6036.
10. Holsinger, L. J., Nichani, D., Pinto, L. H., and Lamb, R. A. (1994). Influenza A virus M2 ion channel protein: A structure-function analysis. J. Virol. 68, 1551-1563.
11. Kida, H., Brown, L. E., and Webster, R. G. (1982). Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus. Virology 122, 38-47.
12. Maassab, H. F., and Bryant, M. L. (1999). The development of live attenuated cold-adapted influenza virus vaccine for humans. Rev. Med. Virol. 9, 237-244.
13. Neumann, G., Watanabe, T., Ito, H., Watanabe, S., Goto, H., Gao, P., Hughes, M., Perez, D. R., Donis, R., Hoffmann, E., Hobom, G., and Kawaoka, Y. (1999). Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. USA 96, 9345-9350.
14. Pinto, L. H., Holsinger, L. J., and Lamb, R. A. (1992). Influenza A virus M2 protein has ion channel activity. Cell 69, 517-528.
15. Sugrue, R. J., Bahadur, G., Zambom, M. C., Hall-Smith, M., Douglas, A. R., and Hay, A. J. (1990). Specific structure alteration of the influenza haemagglutinin by amantadine. EMBO J. 9, 3469-3476.
16. Talon, J., Salvatore, M., O'Neill, R. E., Nakaya, Y., Zheng, H., Muster, T., Garcia-Sastre, A., and Palese, P. (2000). Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proc. Natl. Acad. Sci. USA 97, 4309-4314.
17. Watanabe, T., Watanabe, S., Ito, H., Kida, H., and Kawaoka, Y. (2001). Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity. J. Virol. 75, 5656-5662.
18. Watanabe, T., Watanabe, S., Gabriele, N., Kida, H., and Kawaoka, Y. (2002). Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles. J. Virol. 76, 767-773.
19. Wright, P. W., and Webster, R. G. (2001). Orthomyxoviruses. In "Fields Virology" (D. M. Knipe, and P. M. Howley, Eds.), Lippincott-Raven Publishers, Philadelphia.